Delivery Order SPE2DB22D3301-SPE2DB25FY8AC
- Not listed
- This is a $6,754.90 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lyrica 75 mg capsules and has a period of performance through March 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of...
- This is a delivery order award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The order, valued at $1,133.45, is for the supply of 4,565,938,887 units of Lyrica 75 mg capsules. The contract is a firm-fixed-price delivery order with a completion date of September 26, 2024. It is not a set-aside contract. This delivery order is likely part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical,...
- The U.S. Defense Logistics Agency (DLA) awarded a $2,768.15 firm fixed price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the supply of 4565602832 - Lyrica 100 mg capsules (90 count) and does not have a set-aside designation. This delivery order contract is associated with a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between AmerisourceBergen and DLA Troop Support Medical, which provides a comprehensive...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of pharmaceutical products, specifically 4,565,440,555 Lyrica 75 mg capsules, to support military treatment facilities and other federal healthcare providers. The contract has a firm fixed price of $2,849.89 and an ultimate completion date of August 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, for the supply of Lyrica 75 mg capsules. The award, valued at $3,275.34, was made on February 28, 2024, with a completion date of February 29, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lyrica 50 mg capsules. The $1,182.32 contract has a completion date of July 14, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a comprehensive global pharmaceutical support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,786.46 on July 18, 2025, for the supply of Lyrica 50 mg capsules (90-count units). This contract was awarded on a firm fixed price basis with no set-aside designation, indicating competitive award conditions. The order is scheduled for completion by July 21, 2025, and is being funded through the Medical Supply Chain division of the Department of...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Lyrica 75 mg capsules, with a total ceiling value of $2,195.17 and a performance period through June 16, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,046.57 firm-fixed-price contract is for the delivery of Lyrica 75 mg capsules, a prescription medication for the treatment of neuropathic pain. The contract has a completion date of December 10, 2024 and does not utilize any set-aside requirements, indicating open competition. AmerisourceBergen holds a larger...
- This is a $31,178.17 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the delivery of Lyrica 150 mg capsules to support federal healthcare programs and facilities. The order has a performance period ending on September 12, 2024. This award is part of a larger indefinite-delivery/indefinite-quantity (IDIQ) contract valued at up to $999,999,999 held by AmerisourceBergen...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY8ACDelivery Order
The Defense Logistics Agency awarded a $1,445.82 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 100 unit-dose capsules of Lyrica (pregabalin) 75 mg, with an ultimate completion date of July 21, 2025. This is a competitively awarded, non-set-aside contract with performance in Conshohocken, Pennsylvania, where the vendor maintains its corporate headquarters. The delivery order represents a routine pharmaceutical procurement supporting federal medical supply requirements for military and veteran healthcare systems. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive global pharmaceutical supply vehicle enabling the contractor to provide a broad range of medications, vaccines, medical devices, and healthcare commodities to support Defense Health Agency operations and other federal healthcare systems worldwide. AmerisourceBergen Drug Corp's substantial federal contract portfolio and successful performance on this prime vendor agreement demonstrate its capability to fulfill critical pharmaceutical procurement needs through open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 7/18/25 |